13F Holdings
中文EN

Commodore Capital LP

NEW YORK NY · SEC CIK 0001831942

2026Q22026Q1 9 earlier quarters 🔒
$1.68B2026Q2 reported value
33Positions
68.2%Top 10 weight · largest 13.4%
4 / 8New / sold out
Reported value over time$1.68B2026Q2
26Q126Q2

All 11 quarters on paid plans 🔒

Top 10 holdings % of portfolio

RLAY 13.4%
ELVN 9.9%
ALKS 9.4%
COGT 7.0%
AMLX 6.0%
DFTX 5.6%
SYRE 4.5%
ANRO 4.3%
TNGX 4.2%
EYPT 3.9%

2026Q2 top buys estimated at quarter-end value

TNGX New+$70.33M
EDIT New+$28.80M
EYPT Added+$25.38M
IFRX New+$16.35M
ASMB Added+$11.40M

2026Q2 top sells estimated at quarter-end value

SYRE Reduced-$94.60M
RLAY Reduced-$93.55M
NUVALENT INC Reduced-$90.60M
ALKS Reduced-$62.87M
KYMR Reduced-$57.34M

2026Q2 holdings click a header to sort

Export CSV 🔒
TickerNameValue ▼WeightSharesShare changeChangeEst. flowAction
RLAY RELAY THERAPEUTICS INC $224.52M13.37%12,000,000 -5,000,000-29.4% -$93.55M Reduced
ELVN ENLIVEN THERAPEUTICS INC $166.21M9.90%3,275,000 00.0% — Unchanged
ALKS ALKERMES PLC $157.19M9.36%3,000,000 -1,200,000-28.6% -$62.87M Reduced
COGT COGENT BIOSCIENCES INC $118.03M7.03%3,050,000 161,9935.6% $6.27M Added
AMLX AMYLYX PHARMACEUTICALS INC $101.47M6.04%5,650,000 00.0% — Unchanged
DFTX DEFINIUM THERAPEUTICS INC $94.08M5.60%2,000,000 00.0% — Unchanged
SYRE SPYRE THERAPEUTICS INC $75.18M4.48%846,786 -1,065,594-55.7% -$94.60M Reduced
ANRO ALTO NEUROSCIENCE INC $71.87M4.28%2,723,196 00.0% — Unchanged
TNGX TANGO THERAPEUTICS INC $70.33M4.19%2,250,000 2,250,000— $70.33M New
EYPT EYEPOINT INC $65.78M3.92%4,600,000 1,775,00062.8% $25.38M Added
TYRA TYRA BIOSCIENCES INC $59.89M3.57%1,875,000 -600,000-24.2% -$19.16M Reduced
DMRA DAMORA THERAPEUTICS INC $50.43M3.00%1,939,000 00.0% — Unchanged
CLDX CELLDEX THERAPEUTICS INC NEW $50.23M2.99%1,350,000 -1,346,616-49.9% -$50.11M Reduced
PHVS PHARVARIS N V $49.28M2.93%1,425,000 -493,970-25.7% -$17.08M Reduced
LBRX LB PHARMACEUTICALS INC $48.68M2.90%1,500,000 00.0% — Unchanged
ASMB ASSEMBLY BIOSCIENCES INC $38.88M2.32%1,415,000 415,00041.5% $11.40M Added
EDIT EDITAS MEDICINE INC $28.80M1.72%8,889,000 8,889,000— $28.80M New
KYMR KYMERA THERAPEUTICS INC $28.67M1.71%250,000 -500,000-66.7% -$57.34M Reduced
CATX PERSPECTIVE THERAPEUTICS INC $21.61M1.29%6,336,782 00.0% — Unchanged
IPSC CENTURY THERAPEUTICS INC $21.30M1.27%8,695,652 00.0% — Unchanged
ZURA ZURA BIO LTD $19.18M1.14%3,250,000 00.0% — Unchanged
AVTX AVALO THERAPEUTICS INC $18.82M1.12%1,018,319 535,319110.8% $9.89M Added
IFRX INFLARX NV $16.35M0.97%7,300,000 7,300,000— $16.35M New
— AN2 THERAPEUTICS INC $14.20M0.85%2,933,680 599,96725.7% $2.90M Added
— NUVALENT INC $12.35M0.74%100,000 -733,600-88.0% -$90.60M Reduced
SABS SAB BIOTHERAPEUTICS INC $11.19M0.67%2,870,000 -1,531,500-34.8% -$5.97M Reduced
IKT INHIBIKASE THERAPEUTICS INC $10.96M0.65%5,397,488 00.0% — Unchanged
RLMD RELMADA THERAPEUTICS INC $9.86M0.59%1,425,000 791,099124.8% $5.47M Added
— PEPGEN INC $8.05M0.48%4,475,000 00.0% — Unchanged
— RESEARCH ALLIANCE CORP III $5.35M0.32%500,000 500,000— — First reported
HLXC HELIX ACQUISITION CORP III $5.32M0.32%500,000 00.0% — Unchanged
— LEONABIO INC $4.27M0.25%464,398 00.0% — Unchanged
— VISTAGEN THERAPEUTICS INC $630,2280.04%2,788,620 2,788,620— $630,228 New
ERAS ERASCA INC $00.00%0 -3,175,000-100.0% -$51.37M Sold out
XENE XENON PHARMACEUTICALS INC $00.00%0 -825,000-100.0% -$47.97M Sold out
NRIX NURIX THERAPEUTICS INC $00.00%0 -2,275,000-100.0% -$35.26M Sold out
CRVS CORVUS PHARMACEUTICALS INC $00.00%0 -2,258,735-100.0% -$33.05M Sold out
— SOLENO THERAPEUTICS INC $00.00%0 -652,432-100.0% -$21.84M Sold out
OCUL OCULAR THERAPEUTIX INC $00.00%0 -2,575,000-100.0% -$21.81M Sold out
PALI PALISADE BIO INC $00.00%0 -7,181,062-100.0% -$12.57M Sold out
KPTI KARYOPHARM THERAPEUTICS INC $00.00%0 -1,950,000-100.0% -$10.86M Sold out